TrialIntensive care medicine2021

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.

Lore Vanderbeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.